The Developing Role of CI in a Post-Pandemic World
Dr. Mark Little
Senior Vice President, Intelligence & Insight
Prescient’s fourth annual white paper on strategic imperatives in competitive intelligence (CI) is available to download now.
While some doubted that CI would survive the pandemic, it has proven to be a robust discipline at the heart of the pharma industry and plays a vital role in operations, from developing new drugs to entering new markets.
Alongside research and development, CI is crucial to businesses that want to maximize the value of their science.
Now in its fourth year, Prescient’s research study on strategic imperatives in CI collects feedback from thought leaders across the CI space, from legacy players at the major firms to the industry’s foremost innovators and disruptors.
Download this white paper to learn:
- The top 10 challenges for CI professionals in 2022
- The key CI initiatives, either planned or in play, to address the biggest challenges of 2022
- Which strategic changes adopted during the pandemic are here to stay
The 2022 Strategic Imperatives in Competitive Intelligence Report is your unmissable guide to the issues that will shape CI in the pharmaceutical industry as we enter 2023.
Download your free copy by submitting the form.